Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Bayview Asset Management Reports 9% Passive Stake In Enact Holdings As Of Sept. 20

-Reuters

byMichael Horton

September 30, 2021

1 minute read

-Reuters

ESSA Bancorp Q1 EPS $0.50 Misses $0.58 Estimate

By Benzinga Newsdesk

Today, 6:24 AM

ESSA Bancorp (NASDAQ:ESSA) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.58 by 13.79 percent. This is a 6.38 percent increase over earnings of $0.47 per share from the

ESSA

Jabil Clocks Over 15% Revenue Growth In Q3 Backed By DMS, EMS Segments; Boosts FY22 Outlook

By Anusuya Lahiri

Today, 6:25 AM

Jabil Inc (NYSE:JBL) reported third-quarter FY22 revenue growth of 15.4% year-on-year to $8.33 billion, beating the consensus of $8.22 billion. Segments: Diversified…

JBL

FDA Accepts Gamida’s Filing For Stem Cell Transplant Candidate Under Priority Review

By Ragothaman Srinivasan

Today, 6:25 AM

The U.S. Food and Drug Administration (FDA) has accepted for filing the Gamida Cell’s (NASDAQ: GMDA) Biologics License Application (BLA) for omidubicel in the treatment of patients with blood cancers in need of an allogenic hematopoietic stem cell transplant.

GMDA

Betterware de Mexico Q2 Sales To Decline On Cut In Consumer Spending, Says Analyst

By Shivani Kumaresan

Today, 6:25 AM

Telsey Advisory Group analyst Cristina Fernandez maintained a Moderate Risk rating on Betterware de Mexico SAB De C.V. (NASDAQ:BWMX) and lowered the…

BWMX

Bayview Asset Management Reports 9% Passive Stake In Enact Holdings As Of Sept. 20

Related Posts

ESSA Bancorp Q1 EPS $0.50 Misses $0.58 Estimate

Jabil Clocks Over 15% Revenue Growth In Q3 Backed By DMS, EMS Segments; Boosts FY22 Outlook

FDA Accepts Gamida’s Filing For Stem Cell Transplant Candidate Under Priority Review

Betterware de Mexico Q2 Sales To Decline On Cut In Consumer Spending, Says Analyst